Complications of percutaneous coronary intervention include in-stent restenosis (ISR) and in-stent thrombosis (IST) which have different underlying pathophysiological processes and different treatment strategies. ISR is primarily due to excessive neointimal growth and occurs in 20-30% of bare-metal stents (BMS). Drug-eluting stents (DES) have decreased the rates of ISR (< 10%), but are potentially associated with increased IST related to delayed arterial healing and stent strut exposure. ISR of BMS typically occurs within 6 months of stent deployment. IST usually occurs within 12 months of DES deployment. We present a case of focal ISR and IST within the same BMS, confirmed with intravascular ultrasound, 5 years after deployment in a saphenous vein graft.


Journal article


J Invasive Cardiol

Publication Date





E369 - E371


Angioplasty, Balloon, Coronary, Blood Vessel Prosthesis Implantation, Coronary Angiography, Coronary Artery Bypass, Coronary Restenosis, Follow-Up Studies, Graft Occlusion, Vascular, Humans, Male, Middle Aged, Myocardial Infarction, Saphenous Vein, Stents, Thrombolytic Therapy, Time Factors, Ultrasonography, Interventional